Financhill
Back

Arbutus Biopharma Quote, Financials, Valuation and Earnings

Arbutus Biopharma Price Quote

$3.20
-0.01 (-0.31%)
(Updated: December 21, 2024 at 5:13 AM ET)

Arbutus Biopharma Key Stats

Sell
27
Arbutus Biopharma (ABUS) is a Sell

Day range:
$3.16 - $3.26
52-week range:
$2.21 - $4.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
85.85
P/B ratio:
5.69%

Volume:
3M
Avg. volume:
922.9K
1-year change:
45.25%
Market cap:
$608.3M
Revenue:
$18.1M
EPS:
$-0.43

How Much Does Arbutus Biopharma Make?

Data Unavailable

Is Arbutus Biopharma Growing As A Company?

Data Unavailable

Arbutus Biopharma Stock Price Performance

What Is Arbutus Biopharma 52-Week High & Low?

Arbutus Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arbutus Biopharma?

Data Unavailable

Is Arbutus Biopharma Cash Flow Positive?

Data Unavailable

Arbutus Biopharma Return On Invested Capital

Data Unavailable

Arbutus Biopharma Earnings Date & Stock Price

Arbutus Biopharma Competitors

  • Who Are Arbutus Biopharma's Competitors?
    Below is a list of companies who compete with Arbutus Biopharma or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • Amicus Therapeutics Inc (FOLD)
    • GlycoMimetics Inc (GLYC)
    • Ionis Pharmaceuticals Inc (IONS)

Arbutus Biopharma Dividend Yield

Data Unavailable

Arbutus Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.95%
Revenue: -71.25% -28.55%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable